Center for Biologics Evaluation and Research (CBER)
Food And Drug Administration (FDA)
Department of Health and Human Services (HHS)
Become a part of an agency that touches the lives of every American!
The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Tissues and Advanced Therapies’ (OTAT), Division of Cellular and Gene Therapies (DCGT), Cell Therapies Branch (CTB) is recruiting full-time review scientists.
DCGT is strongly committed to bringing FDA and other scientists, patient advocates, and the public together in partnership to develop new therapies for the 21st Century, while protecting human subjects and ensuring product safety. The candidate will be a part of a cutting-edge and fast-paced scientific and regulatory environment.
If you specialize in
Cell Therapy, Cell and Stem Cell Biology, Microbiology,
Cellular Immunology, Cancer Biology, and/or Biomedical Engineering,
we are looking for you.
What Does CBER Have to Offer You?
CBER is committed to facilitating the development of new biological products, to include but not limited to cell and gene therapies, plasma protein therapeutics, and select medical devices for a broad range of complex and often times life-threatening diseases as well as rare diseases. By joining CBER, you will fuel your own passions and use your many talents, skills, and experiences to help CBER successfully navigate the challenges and opportunities of 21st Century medicine.
Responsibilities: As the selected candidate, you will have the opportunity to:
Perform scientific review, interpretation, and documentation of product manufacturing data to evaluate the safety and quality of cell therapy products (e.g., stem cells, cancer vaccines, cellular immunotherapies, engineered tissue, medical devices) in regulatory submissions to FDA.
Contribute to guidance and policy development activities relevant to cell therapy.
Additional Qualifications: Candidates are expected to be proficient in applying relevant scientific knowledge and research experience to support multi-disciplinary scientific and review of regulatory submissions. In addition, the candidate must have strong collaborative skills, excellent written and oral communication skills, and evidence of leadership potential.
Preferred Specialized Experience: Postdoctoral experience is highly preferred. Also, knowledge of federal regulations applicable to drugs, biologics, and medical devices is helpful but not a requirement for consideration.
Foreign Education: If you are using education completed in foreign colleges or universities to meet the qualification requirements, you must show that the education credentials have been evaluated by a private organization that specializes in interpretation of foreign education programs and such education has been deemed equivalent to that gained in an accredited U.S. education program; or full credit has been given for the courses at a U.S. accredited college or university. For further information, visit the U.S. Department of Education website for Foreign Education Evaluation.
Salary: Salary is commensurate with education/experience.
Location: FDA White Oak Campus in Silver Spring, MD
Conditions of Employment: This position will be filled through the Service Fellowship program. The appointment provides up to (4) years with opportunities for renewal. Applications will ONLY be accepted from U.S. citizens and/or permanent residents (green card). No previous Federal experience is required. Appointment does not confer any entitlement to a position in the competitive service, and there is no entitlement to Merit Systems Protection Board (MSPB) appeals rights.
Prohibited financial interest restrictions may apply. For additional information on the prohibited financial interests, please visit the FDA Ethics and Integrity Office website at FDA Ethics and Integrity Office.
How to Apply: If you’re seeking a challenging and rewarding career opportunity, we invite you to apply today by completing the following step:
Submit a statement of interest, resume or curriculum vitae (CV) detailing relevant experience, transcripts, names/contact information for three references, proof of U.S. citizenship or lawful permanent residency status, and other supporting documentations to Melanie Eacho at email@example.com. Applications will be accepted through January 31, 2021. However, candidates will be considered as received. For best consideration, please submit your application as soon as possible. Please reference Job Code: OTAT-21-02-BES.
HHS/FDA is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status.
Telecommuting is allowed.
Internal Number: OTAT-21-02-BES
About FDA/Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research (CBER) within the Food and Drug Administration (FDA) regulates biological products for human use under applicable federal laws, including the Public Health Service Act and the Federal Food, Drug and Cosmetic Act. CBER protects and advances the public health by ensuring that biological products are safe and effective and available to those who need them. CBER also provides the public with information to promote the safe and appropriate use of biological products.